min zhan

Dr. min zhan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HMHaowen Ma
Haowen Ma
CLCong Liu
Cong Liu
ZLZihao Li
Zihao Li
QYQiuchun Yu
Qiuchun Yu
HXHuilan Xiong
Huilan Xiong
QCQian Cai
Qian Cai

15 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ZCZhongqiang Cao
Zhongqiang Cao
JCJunjie Cheng
Junjie Cheng
ZCZebin Chen
Zebin Chen
XLXi Lei
Xi Lei
LYLing Yang
Ling Yang
XLXuejuan Li
Xuejuan Li
Background: Although triptorelin acetate (TA) is generally considered a safe medication, severe adverse drug reactions (ADRs) to triptorelin have occurred. In this study, we present the largest retrospective analysis of ADRs related to TA during the treatment of pediatric central precocious puberty. Methods: We describe a total of 38 suspected cases of TA-induced ADRs reported to the pharma-covigilance center of Shenzhen Children’s Hospital from September 2015 to December 2022. Causality assessment was carried out using the validated Kramer’s algorithm. The severity of ADRs was evaluated using the Modified Hartwig and Siegel Scale. Results: The most common ADRs attributed to TA were damage to the cutaneous tissues (29.3%) and reactions affecting the systemic and digestive systems (20.7%). The majority (61.1%) of ADRs occurred within 2 hours of administration. Among the 12 patients with severe ADRs, the three most frequent symptoms were anaphylactic reactions, hip synovitis, and arthralgia. Additional-ly, six patients experienced ADRs due to a change in the manufacturing process. Conclusion: The majority of ADRs observed in pediatric cases were type I anaphylactic reactions, which are rare but life-threatening. It is advisable to perform skin prick tests and intradermal tests when switching pharmaceutical manufacturers.